市場調査レポート
商品コード
1446188

牛ヘルスケアの世界市場2024-2028

Global Cattle Healthcare Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 169 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
牛ヘルスケアの世界市場2024-2028
出版日: 2024年02月27日
発行: TechNavio
ページ情報: 英文 169 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

牛ヘルスケア市場は、2023年から2028年にかけて44億7,000万米ドル、予測期間中のCAGRは8.91%で成長すると予測されています。

当レポートでは、牛ヘルスケア市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。牛の疾病負担の増加、予防ヘルスケア対策の重要性に対する畜産農家の意識の高まり、世界の牛肉・乳製品需要の増加などが市場を牽引しています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 7.53%
CAGR 8.91%
増分額 44億7,000万米ドル

本調査では、今後数年間の牛ヘルスケア市場の成長を促進する主な要因の一つとして、畜産業へのシフトの高まりを挙げています。また、獣医療と技術の進歩、獣医療における遠隔医療の動向の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 世界の牛ヘルスケア市場 2018-2022
  • タイプセグメント分析 2018-2022
  • 製品セグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 食用牛:市場規模と予測 2023-2028
  • 乳牛:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第7章 市場セグメンテーション:製品別

  • 市場セグメント
  • 比較:製品別
  • 医薬品:市場規模と予測 2023-2028
  • 飼料添加物:市場規模と予測 2023-2028
  • ワクチン:市場規模と予測 2023-2028
  • その他:市場規模と予測 2023-2028
  • 市場機会:製品別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • フランス:市場規模と予測 2023-2028
  • インド:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Biozyme Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • IDEXX Laboratories Inc.
  • ImmuCell Corp.
  • Innovative Diagnostics
  • Kyoritsuseiyaku Corp.
  • Merck and Co. Inc.
  • Norbrook Laboratories Ltd.
  • Phibro Animal Health Corp.
  • Thermo Fisher Scientific Inc.
  • Vetoquinol SA
  • Virbac Group
  • Zoetis Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global cattle healthcare market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Products Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Beef cattle - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Beef cattle - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Beef cattle - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Beef cattle - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Dairy cattle - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Dairy cattle - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Dairy cattle - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Dairy cattle - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Type ($ billion)
  • Exhibits43: Data Table on Market opportunity by Type ($ billion)
  • Exhibits44: Chart on Product - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Product
  • Exhibits47: Data Table on Comparison by Product
  • Exhibits48: Chart on Pharmaceuticals - Market size and forecast 2023-2028 ($ billion)
  • Exhibits49: Data Table on Pharmaceuticals - Market size and forecast 2023-2028 ($ billion)
  • Exhibits50: Chart on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Feed additives - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Feed additives - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by Product ($ billion)
  • Exhibits65: Data Table on Market opportunity by Product ($ billion)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Biozyme Inc. - Overview
  • Exhibits116: Biozyme Inc. - Product / Service
  • Exhibits117: Biozyme Inc. - Key offerings
  • Exhibits118: Boehringer Ingelheim International GmbH - Overview
  • Exhibits119: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits120: Boehringer Ingelheim International GmbH - Key news
  • Exhibits121: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits122: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits123: Ceva Sante Animale - Overview
  • Exhibits124: Ceva Sante Animale - Product / Service
  • Exhibits125: Ceva Sante Animale - Key offerings
  • Exhibits126: Elanco Animal Health Inc. - Overview
  • Exhibits127: Elanco Animal Health Inc. - Product / Service
  • Exhibits128: Elanco Animal Health Inc. - Key offerings
  • Exhibits129: IDEXX Laboratories Inc. - Overview
  • Exhibits130: IDEXX Laboratories Inc. - Business segments
  • Exhibits131: IDEXX Laboratories Inc. - Key news
  • Exhibits132: IDEXX Laboratories Inc. - Key offerings
  • Exhibits133: IDEXX Laboratories Inc. - Segment focus
  • Exhibits134: ImmuCell Corp. - Overview
  • Exhibits135: ImmuCell Corp. - Business segments
  • Exhibits136: ImmuCell Corp. - Key offerings
  • Exhibits137: ImmuCell Corp. - Segment focus
  • Exhibits138: Innovative Diagnostics - Overview
  • Exhibits139: Innovative Diagnostics - Product / Service
  • Exhibits140: Innovative Diagnostics - Key offerings
  • Exhibits141: Kyoritsuseiyaku Corp. - Overview
  • Exhibits142: Kyoritsuseiyaku Corp. - Product / Service
  • Exhibits143: Kyoritsuseiyaku Corp. - Key offerings
  • Exhibits144: Merck and Co. Inc. - Overview
  • Exhibits145: Merck and Co. Inc. - Business segments
  • Exhibits146: Merck and Co. Inc. - Key news
  • Exhibits147: Merck and Co. Inc. - Key offerings
  • Exhibits148: Merck and Co. Inc. - Segment focus
  • Exhibits149: Norbrook Laboratories Ltd. - Overview
  • Exhibits150: Norbrook Laboratories Ltd. - Product / Service
  • Exhibits151: Norbrook Laboratories Ltd. - Key offerings
  • Exhibits152: Phibro Animal Health Corp. - Overview
  • Exhibits153: Phibro Animal Health Corp. - Business segments
  • Exhibits154: Phibro Animal Health Corp. - Key offerings
  • Exhibits155: Phibro Animal Health Corp. - Segment focus
  • Exhibits156: Thermo Fisher Scientific Inc. - Overview
  • Exhibits157: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits158: Thermo Fisher Scientific Inc. - Key news
  • Exhibits159: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits160: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits161: Vetoquinol SA - Overview
  • Exhibits162: Vetoquinol SA - Business segments
  • Exhibits163: Vetoquinol SA - Key news
  • Exhibits164: Vetoquinol SA - Key offerings
  • Exhibits165: Vetoquinol SA - Segment focus
  • Exhibits166: Virbac Group - Overview
  • Exhibits167: Virbac Group - Business segments
  • Exhibits168: Virbac Group - Key news
  • Exhibits169: Virbac Group - Key offerings
  • Exhibits170: Virbac Group - Segment focus
  • Exhibits171: Zoetis Inc. - Overview
  • Exhibits172: Zoetis Inc. - Business segments
  • Exhibits173: Zoetis Inc. - Key news
  • Exhibits174: Zoetis Inc. - Key offerings
  • Exhibits175: Zoetis Inc. - Segment focus
  • Exhibits176: Inclusions checklist
  • Exhibits177: Exclusions checklist
  • Exhibits178: Currency conversion rates for US$
  • Exhibits179: Research methodology
  • Exhibits180: Validation techniques employed for market sizing
  • Exhibits181: Information sources
  • Exhibits182: List of abbreviations
目次
Product Code: IRTNTR77493

The cattle healthcare market is forecasted to grow by USD 4.47 bn during 2023-2028, accelerating at a CAGR of 8.91% during the forecast period. The report on the cattle healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of cattle diseases, growing awareness among cattle farmers on importance of preventive healthcare measures, and increasing demand for beef and dairy products worldwide.

Technavio's cattle healthcare market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.53%
CAGR8.91%
Incremental Value$4.47bn

By Type

  • Beef cattle
  • Dairy cattle

By Product

  • Pharmaceuticals
  • Feed additives
  • Vaccines
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising shift towards animal farming as one of the prime reasons driving the cattle healthcare market growth during the next few years. Also, advancements in veterinary medicine and technology and growing trend of telemedicine in veterinary care facilitates will lead to sizable demand in the market.

The report on the cattle healthcare market covers the following areas:

  • Cattle healthcare market sizing
  • Cattle healthcare market forecast
  • Cattle healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cattle healthcare market vendors that include Biozyme Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Zovix Pharmaceuticals. Also, the cattle healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global cattle healthcare market 2018 - 2022
  • 4.2 Type Segment Analysis 2018 - 2022
  • 4.3 Products Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022
  • 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by Type

  • 6.1 Market segments
  • 6.2 Comparison by Type
  • 6.3 Beef cattle - Market size and forecast 2023-2028
  • 6.4 Dairy cattle - Market size and forecast 2023-2028
  • 6.5 Market opportunity by Type

7 Market Segmentation by Product

  • 7.1 Market segments
  • 7.2 Comparison by Product
  • 7.3 Pharmaceuticals - Market size and forecast 2023-2028
  • 7.4 Feed additives - Market size and forecast 2023-2028
  • 7.5 Vaccines - Market size and forecast 2023-2028
  • 7.6 Others - Market size and forecast 2023-2028
  • 7.7 Market opportunity by Product

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 France - Market size and forecast 2023-2028
  • 9.9 India - Market size and forecast 2023-2028
  • 9.10 Germany - Market size and forecast 2023-2028
  • 9.11 China - Market size and forecast 2023-2028
  • 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 Biozyme Inc.
  • 12.4 Boehringer Ingelheim International GmbH
  • 12.5 Ceva Sante Animale
  • 12.6 Elanco Animal Health Inc.
  • 12.7 IDEXX Laboratories Inc.
  • 12.8 ImmuCell Corp.
  • 12.9 Innovative Diagnostics
  • 12.10 Kyoritsuseiyaku Corp.
  • 12.11 Merck and Co. Inc.
  • 12.12 Norbrook Laboratories Ltd.
  • 12.13 Phibro Animal Health Corp.
  • 12.14 Thermo Fisher Scientific Inc.
  • 12.15 Vetoquinol SA
  • 12.16 Virbac Group
  • 12.17 Zoetis Inc.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations